Partners In Investing

At GMO’s 2024 Conference, we contemplated the macro fog but concentrated on the fundamentals, showcasing for our clients numerous pockets of value that are being largely overlooked.

GMO has always believed that an objective and disciplined assessment of valuations is critical. We introduce our active, differentiated GMO Value approach, which goes beyond traditional value metrics.

With U.S. Quality (QLTY) and International Quality (QLTI) active ETFs available, we revisit why we believe Quality equity can be a core portfolio holding, resilient to economic headwinds and market drawdowns.

In a world where many stocks are being driven ever higher by positive sentiment and investor optimism, some fundamentally sound but unloved companies are trading at extraordinary discounts.

In GMO’s latest Quarterly Valuation Update, we offer our Q3 assessment: Local currency rates and FX screen attractive, while credit is neutral.

Lucas White discusses market sentiment in clean energy, including recent market moves, the divergence between valuations and earnings expectations, and conditions that can lead to such dislocations.

GMO’s Multi-Asset Credit Strategy builds on the firm’s 30-year history managing fixed income solutions on behalf of institutional and financial intermediary clients by utilizing a combination of fundamental and quantitative invest...

Ben Inker explains how a valuation-sensitive, multi-asset portfolio can improve traditional strategic allocations.